Breaking Federal Judge Fines DHS for Contempt Over Immigration Agent Cell Phone Data D.C. Prosecutor Disputes Trump’s Claim of Lincoln Memorial Vandalism Atlanta Falcons Linebacker Jalon Walker Out for 2026 Season with Torn ACL Preakness Stakes Date Announcement Looms Amidst Triple Crown Spacing Debate Connecticut DOC to End In-Cell Restraints Under Settlement

Wednesday August 5, 2026

Section

Channels

Press Release

Stewards Leadership Provides Mid-Year Shareholder Update

Stewards Inc. · Jul 21

Press Release

Omai Gold to Present at the Precious Metals & Critical Minerals Virtual Investor Conference on July 23rd

Virtual Investor Conferences · Jul 21

Press Release

Barrick Announces Investment in Kingfisher Metals

Barrick Mining Corporation · Jul 21

Press Release

Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026

Vicor Corporation · Jul 21

Press Release

Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T

Tempest Therapeutics · Jul 21

Press Release

CEI Expands Executive Leadership to Accelerate the Next Generation of AI-Native Enterprise Transformation

CEI · Jul 21

Press Release

Talisker Reports Mustang Underground Face Sample Results and Defines a 127 metre Strike Length High-grade Shoot Averaging 22 g/t on the 1045 Level including 610 g/t over 0.51 of a metre

Talisker Resources Ltd. · Jul 21

Press Release

OpenFX to Offer NGOs Cross-Border FX at Cost

OpenFX · Jul 21

Press Release

PBS Biotech Wins 2026 Cell Products Development of the Year Award

PBS Biotech Inc. · Jul 21

Press Release

How Automation Is Reshaping the Bubble Tea and Fast-Casual Boom

MenuSifu Inc · Jul 21

Press Release

Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer

Altesa Biosciences Inc. · Jul 21

Press Release

Lumeris Partners With Schmitt-Thompson Clinical Content to Advance Tom™ Symptom-Checking Capability with Evidence-Based Telehealth Triage Guidance

Lumeris · Jul 21

Press Release

Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis

Nektar Therapeutics · Jul 21

← Previous 1 … 1,825 1,826 1,827 … 1,859 Next →